AGIO - Agios Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 53.74B
Enterprise Value 33.16B
Trailing P/E N/A
Forward P/E 1-11.01
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)53.20
Price/Book (mrq)4.54
Enterprise Value/Revenue 344.95
Enterprise Value/EBITDA 6-9.60

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Jun 30, 2018

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-477.88%

Management Effectiveness

Return on Assets (ttm)-23.89%
Return on Equity (ttm)-48.79%

Income Statement

Revenue (ttm)70.33M
Revenue Per Share (ttm)1.34
Quarterly Revenue Growth (yoy)256.20%
Gross Profit (ttm)-249.67M
EBITDA -329.38M
Net Income Avi to Common (ttm)-324.99M
Diluted EPS (ttm)-6.169
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)716.91M
Total Cash Per Share (mrq)12.36
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)8.88
Book Value Per Share (mrq)14.21

Cash Flow Statement

Operating Cash Flow (ttm)-318.56M
Levered Free Cash Flow (ttm)-180.58M

Trading Information

Stock Price History

Beta (3Y Monthly) 2.10
52-Week Change 3-6.13%
S&P500 52-Week Change 37.44%
52 Week High 399.820
52 Week Low 351.620
50-Day Moving Average 372.299
200-Day Moving Average 382.344

Share Statistics

Avg Vol (3 month) 3392.45k
Avg Vol (10 day) 3577.03k
Shares Outstanding 557.99M
Float 50.76M
% Held by Insiders 112.82%
% Held by Institutions 196.05%
Shares Short (Sep 28, 2018) 45.66M
Short Ratio (Sep 28, 2018) 417.65
Short % of Float (Sep 28, 2018) 419.49%
Short % of Shares Outstanding (Sep 28, 2018) 49.76%
Shares Short (prior month Aug 31, 2018) 45.08M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A